SABCS: In Early Breast CA, Breast-Conserving Tx Beats Mastectomy

Share this content:
SABCS: In Early Breast CA, Breast-Conserving Tx Beats Mastectomy
SABCS: In Early Breast CA, Breast-Conserving Tx Beats Mastectomy

THURSDAY, Dec. 10, 2015 (HealthDay News) -- Women with early-stage breast cancer may survive longer if they opt for lumpectomy followed by radiation, rather than a mastectomy, a new study suggests. The findings were scheduled to be presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 8 to 12 in San Antonio.

The study included 37,207 Dutch women. Of nearly 21,734 patients who underwent lumpectomy plus radiation, 76.8 percent were still alive 10 years later. That compared with only 59.7 percent of women who'd undergone a mastectomy with no radiation. Women who chose lumpectomy and radiation were younger and more likely to receive hormonal therapy. But even with those differences considered, women in the lumpectomy group were 21 percent more likely to be alive 10 years after treatment.

For disease-free survival, the researchers found no significant difference between those receiving breast-conserving therapy and those receiving mastectomy after adjusting for confounding factors. In analysis of subcohort data, the team found that patients who received breast-conserving therapy developed regional recurrences and distant metastases less often than those who received mastectomy.

"I think these results offer women important information to discuss with their doctors when making a treatment decision for early-stage breast cancer," lead researcher Sabine Seisling, Ph.D., of the Netherlands Comprehensive Cancer Organization in Utrecht, told HealthDay.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC Concerned About Falling Flu Vaccination Rates

CDC Concerned About Falling Flu Vaccination Rates

Decline among vulnerable older adults is of particular concern

One in Five With Non-Valvular A-Fib Receiving Digoxin

One in Five With Non-Valvular A-Fib Receiving Digoxin

Indication for digoxin use was considered inappropriate in 59.8 percent in Turkish cohort

Rapid, Successful Response to ART for Many Patients With HIV

Rapid, Successful Response to ART for Many Patients ...

Factors associated with virological success include having undetectable viral load, use of three drugs

is free, fast, and customized just for you!

Already a member?

Sign In Now »